METTL3 and non-small cell lung carcinoma: Mettl3 sustains the stabilization of the c-MYC mRNA via the m6A modification to accelerate tumorigenesis in OSCC [36] and promotes YAP translation to induce drug resistance and metastasis in NSCLC [37].